{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:54:47Z","timestamp":1769500487349,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,2,4]],"date-time":"2010-02-04T00:00:00Z","timestamp":1265241600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00345-010-0514-x","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T12:46:35Z","timestamp":1265201195000},"page":"425-430","source":"Crossref","is-referenced-by-count":21,"title":["Impact of patient age on outcome following bladder-preserving treatment for non-muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Yasuo","family":"Kohjimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Iba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyo","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Uekado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,4]]},"reference":[{"key":"514_CR1","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/cncr.21354","volume":"104","author":"GR Prout Jr","year":"2005","unstructured":"Prout GR Jr, Wesley MN, Yancik R et al (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104:1638\u20131647","journal-title":"Cancer"},{"key":"514_CR2","unstructured":"Jones JS, Campbell SC (2007) Non-muscle invasive bladder cancer (Ta, T1, and CIS). In: Wein AJ, Kavoussi LR, Novick AC et al. (eds) Campbell-Walsh urology, vol 3, 9th edn. WB Saunders, Philadelphia, pp 2447\u20132467"},{"key":"514_CR3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","volume":"175","author":"FN Joudi","year":"2006","unstructured":"Joudi FN, Smith BJ, O\u2019Donnell MA et al (2006) The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol 175:1634\u20131639","journal-title":"J Urol"},{"key":"514_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","volume":"70","author":"HW Herr","year":"2007","unstructured":"Herr HW (2007) Age and outcome of superficial bladder cancer treated with bacille Calmette\u2013Gu\u00e9rin therapy. Urology 70:65\u201368","journal-title":"Urology"},{"key":"514_CR5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","volume":"150","author":"TL Ratliff","year":"1993","unstructured":"Ratliff TL, Ritchey JK, Yuan JJ et al (1993) T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J Urol 150:1018\u20131023","journal-title":"J Urol"},{"key":"514_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2006.05.003","volume":"24","author":"R Solana","year":"2006","unstructured":"Solana R, Pawelec G, Tarazona R (2006) Aging and innate immunity. Immunity 24:491\u2013494","journal-title":"Immunity"},{"key":"514_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1532-5415.1986.tb06335.x","volume":"34","author":"JS Goodwin","year":"1986","unstructured":"Goodwin JS, Samet JM, Key CR et al (1986) Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc 34:20\u201326","journal-title":"J Am Geriatr Soc"},{"key":"514_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1078-1439(03)00139-X","volume":"22","author":"R Madeb","year":"2004","unstructured":"Madeb R, Messing EM (2004) Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 22:86\u201392","journal-title":"Urol Oncol"},{"key":"514_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1014444601158","volume":"33","author":"M Takashi","year":"2002","unstructured":"Takashi M, Wakai K, Hattori T et al (2002) Multivariate evaluation of factors affecting recurrence, progression, and survival in patients with superficial bladder cancer treated with intravesical bacillus Calmette\u2013Gu\u00e9rin (Tokyo 172 strain) therapy: significance of concomitant carcinoma in situ. Int Urol Nephrol 33:41\u201347","journal-title":"Int Urol Nephrol"},{"key":"514_CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2006.11.004","volume":"51","author":"ME Nielsen","year":"2007","unstructured":"Nielsen ME, Shariat SF, Karakiewicz PI et al (2007) Advance age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51:699\u2013706","journal-title":"Eur Urol"},{"key":"514_CR11","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der Meijden AP, Lamm DL (2002) Intravesical bacillus Calmette\u2013Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970","journal-title":"J Urol"},{"key":"514_CR12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","volume":"63","author":"A B\u00f6hle","year":"2004","unstructured":"B\u00f6hle A, Bock PR (2004) Intravesical bacille Calmette\u2013Gu\u00e9rin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63:682\u2013686","journal-title":"Urology"},{"key":"514_CR13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","volume":"147","author":"HW Herr","year":"1992","unstructured":"Herr HW, Wartinger DD, Fair WR et al (1992) Bacillus Calmette\u2013Guerin therapy for superficial bladder cancer: a 10-year followup. J Urol 147:1020\u20131023","journal-title":"J Urol"},{"key":"514_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","volume":"56","author":"PU Malmstrom","year":"2009","unstructured":"Malmstrom PU, Sylvester RJ, Crawford DE et al (2009) An individual patient data meta-analysis of the long-term outcome of randomized studies comparing intravesical mitomycin C versus bacillus Calmette\u2013Guerin for non-muscle-invasive bladder cancer. Eur Urol 56:247\u2013256","journal-title":"Eur Urol"},{"key":"514_CR15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","volume":"166","author":"HW Herr","year":"2001","unstructured":"Herr HW, Sogani PC (2001) Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166:1296\u20131299","journal-title":"J Urol"},{"key":"514_CR16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.urology.2004.03.034","volume":"64","author":"BK Hollenbeck","year":"2004","unstructured":"Hollenbeck BK, Miller DC, Taub D et al (2004) Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80\u00a0years or older. Urology 64:292\u2013297","journal-title":"Urology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-010-0514-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-010-0514-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-010-0514-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:35:47Z","timestamp":1559050547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-010-0514-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1007\/s00345-010-0514-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,4]]}}}